Which pharmaceutical company is currently producing Mitotane? Is it an original drug?

Mitotane (Mitotane) is an oral anti-tumor drug used to treat adrenocortical cancer (ACC). Its active ingredient is a methyl chloride derivative compound. This drug was first developed by the American pharmaceutical company Bristol-Myers Squibb (Bristol-Myers Squibb), so its product is considered the original drug of mitotane. Mitotane is one of the few classic drugs specifically designed to treat rare tumors and has been an important treatment option for patients with ACC over the past few decades.

Currently, the brand name of mitotane’s original drug isLysodren. It was originally developed by Bristol-Myers Squibb, and now HRA Pharma holds the production and commercialization rights in some global markets. HRA Pharma is a European pharmaceutical company specializing in the treatment of rare diseases and endocrine diseases. They have played a key role in the continued supply, quality control and registration management of mitotane. LysodrenAs an original research product, it is currently legally marketed and used in Europe, the United States and other regions.

On the basis of the original drug, there are also some generic versions of mitotane. However, due to its extremely rare clinical use and high production process and quality requirements, there are currently only a limited number of generic drugs available globally, and they are mainly concentrated in individual countries or obtained through special import channels. In comparison, the quality, efficacy and stability of the original Lysodren are more guaranteed, and it is also the version that doctors are more likely to recommend.

In summary, mitotane is still mainly the original drug Lysodren and is produced by HRA Pharma. Although there may be some generic versions on the market, since the diseases mitotane is used to treat are rare and have high drug quality requirements, patients are recommended to give priority to the original drug to ensure therapeutic efficacy and safety.

Reference: https://go.drugbank.com/drugs/

xa0